IBDEI2J5 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,42914,0)
 ;;=N40.0^^162^2050^8
 ;;^UTILITY(U,$J,358.3,42914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42914,1,3,0)
 ;;=3^Enlarged prostate w/o LUTS
 ;;^UTILITY(U,$J,358.3,42914,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,42914,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,42915,0)
 ;;=N41.0^^162^2050^2
 ;;^UTILITY(U,$J,358.3,42915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42915,1,3,0)
 ;;=3^Acute prostatitis
 ;;^UTILITY(U,$J,358.3,42915,1,4,0)
 ;;=4^N41.0
 ;;^UTILITY(U,$J,358.3,42915,2)
 ;;=^259106
 ;;^UTILITY(U,$J,358.3,42916,0)
 ;;=N41.1^^162^2050^5
 ;;^UTILITY(U,$J,358.3,42916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42916,1,3,0)
 ;;=3^Chronic prostatitis
 ;;^UTILITY(U,$J,358.3,42916,1,4,0)
 ;;=4^N41.1
 ;;^UTILITY(U,$J,358.3,42916,2)
 ;;=^186931
 ;;^UTILITY(U,$J,358.3,42917,0)
 ;;=N41.2^^162^2050^1
 ;;^UTILITY(U,$J,358.3,42917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42917,1,3,0)
 ;;=3^Abscess of prostate
 ;;^UTILITY(U,$J,358.3,42917,1,4,0)
 ;;=4^N41.2
 ;;^UTILITY(U,$J,358.3,42917,2)
 ;;=^270416
 ;;^UTILITY(U,$J,358.3,42918,0)
 ;;=N40.1^^162^2050^7
 ;;^UTILITY(U,$J,358.3,42918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42918,1,3,0)
 ;;=3^Enlarged prostate w/ LUTS
 ;;^UTILITY(U,$J,358.3,42918,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,42918,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,42919,0)
 ;;=N40.2^^162^2050^10
 ;;^UTILITY(U,$J,358.3,42919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42919,1,3,0)
 ;;=3^Nodular prostate w/o LUTS
 ;;^UTILITY(U,$J,358.3,42919,1,4,0)
 ;;=4^N40.2
 ;;^UTILITY(U,$J,358.3,42919,2)
 ;;=^5015691
 ;;^UTILITY(U,$J,358.3,42920,0)
 ;;=N40.3^^162^2050^9
 ;;^UTILITY(U,$J,358.3,42920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42920,1,3,0)
 ;;=3^Nodular prostate w/ LUTS
 ;;^UTILITY(U,$J,358.3,42920,1,4,0)
 ;;=4^N40.3
 ;;^UTILITY(U,$J,358.3,42920,2)
 ;;=^5015692
 ;;^UTILITY(U,$J,358.3,42921,0)
 ;;=N40.1^^162^2050^3
 ;;^UTILITY(U,$J,358.3,42921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42921,1,3,0)
 ;;=3^BPH w/ LUTS
 ;;^UTILITY(U,$J,358.3,42921,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,42921,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,42922,0)
 ;;=R97.2^^162^2050^6
 ;;^UTILITY(U,$J,358.3,42922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42922,1,3,0)
 ;;=3^Elevasted PSA
 ;;^UTILITY(U,$J,358.3,42922,1,4,0)
 ;;=4^R97.2
 ;;^UTILITY(U,$J,358.3,42922,2)
 ;;=^5019748
 ;;^UTILITY(U,$J,358.3,42923,0)
 ;;=Z12.5^^162^2050^11
 ;;^UTILITY(U,$J,358.3,42923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42923,1,3,0)
 ;;=3^Screen for Malig Neop of Prostate
 ;;^UTILITY(U,$J,358.3,42923,1,4,0)
 ;;=4^Z12.5
 ;;^UTILITY(U,$J,358.3,42923,2)
 ;;=^5062688
 ;;^UTILITY(U,$J,358.3,42924,0)
 ;;=D29.21^^162^2051^2
 ;;^UTILITY(U,$J,358.3,42924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42924,1,3,0)
 ;;=3^Benign neoplasm of right testis
 ;;^UTILITY(U,$J,358.3,42924,1,4,0)
 ;;=4^D29.21
 ;;^UTILITY(U,$J,358.3,42924,2)
 ;;=^5002093
 ;;^UTILITY(U,$J,358.3,42925,0)
 ;;=D29.22^^162^2051^1
 ;;^UTILITY(U,$J,358.3,42925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42925,1,3,0)
 ;;=3^Benign neoplasm of left testis
 ;;^UTILITY(U,$J,358.3,42925,1,4,0)
 ;;=4^D29.22
 ;;^UTILITY(U,$J,358.3,42925,2)
 ;;=^5002094
 ;;^UTILITY(U,$J,358.3,42926,0)
 ;;=E29.1^^162^2051^15
 ;;^UTILITY(U,$J,358.3,42926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42926,1,3,0)
 ;;=3^Testicular hypofunction
 ;;^UTILITY(U,$J,358.3,42926,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,42926,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,42927,0)
 ;;=N43.3^^162^2051^9
 ;;^UTILITY(U,$J,358.3,42927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42927,1,3,0)
 ;;=3^Hydrocele, unspec
